The European Commission presented today its much awaited and ambitious Pharmaceutical Strategy for Europe. The patient-centered strategy unveiled by Health Commissioner Stella Kyriakides and Vice-President Margaritis Schinas aims to ensure the quality and safety of medicines in the EU while boosting the sector’s global competitiveness. Building on the EU’s strong foundations and comprehensive pharmaceuticals system, it will ensure that patients have access to high-quality, effective and safe medicines.

Throughout the last months, EFCG has been working closely with the European Commission to identify the root causes of medicines shortages, map the existing industrial network and propose a series of measures to be rapidly implemented at EU level within the framework of the Pharmaceutical Roadmap.

Europe’s health sovereignty will depend on its ability to maintain and develop its existing industrial base as well as investing in new technologies to selectively reshore essential medicines supply chains.

Read our full press release.